Investigating activity in hospitalized patients with chronic obstructive pulmonary disease: A pilot study

Heart and Lung: Journal of Acute and Critical Care

Volumn 39, Issue 4, 2010, Pages 319-330

  Winkelman, Chris ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; AZITHROMYCIN; CEFTAZIDIME; FAMOTIDINE; FLUNISOLIDE; FUROSEMIDE; GLIPIZIDE; HEPARIN; HYDROCHLOROTHIAZIDE; INTERLEUKIN 10; INTERLEUKIN 6; IPRATROPIUM BROMIDE; ISOSORBIDE; LISINOPRIL; METFORMIN; METOPROLOL; MOXIFLOXACIN; OMEPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PRAMIPEXOLE; PREDNISONE; PROPOFOL;

ACTIMETRY; ADULT; AGED; ARTICLE; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; HYPOXIA; INTENSIVE CARE UNIT; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ACTIGRAPHY; ADULT; AGED; ANALYSIS OF VARIANCE; APACHE; CRITICAL ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OHIO; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REST; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77954313900     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2009.09.004     Document Type: Article

References (58)

1. Wust R.C., Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstr Pulm Dis 2007, 2:289-300.
2. Rochester C.L. Exercise training in chronic obstructive pulmonary disease. J Rehabil Res Dev 2003, 40:59-80.
3. Morris P.E. Moving our critically ill patients: mobility barriers and benefits. Crit Care Clin 2007, 23:1-20.
4. Reid M.B., Andrade F.H., Balke C.W., Esser K.A. Redox mechanisms of muscle dysfunction in inflammatory disease. Phys Med Rehabil Clin North Am 2005, 16:925-949.
5. Winkelman C. Inactivity and inflammation in the critically ill patient. Crit Care Clin 2007, 23:21-34.
6. Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharm Rev 2004, 56:515-548.
7. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J 2001, 18:50s-59s.
8. Vlicek J. The cytokines: an overview 2003, Elsevier, New York.
9. Ozaki K., Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 2002, 277:29355-29358.
10. Dougherty D.E., Briggs D.E. Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis. Clin Cornerstone 2004, 6(Suppl):S5-S16.
11. Spurzem J.R., Rennard S.I. Pathognesis of COPD. Semin Respir Crit Care Med 2005, 26:142-153.
12. Kishimoto T. Interleukin-6 2003, Elsevier, New York.
13. Reid P.T., Sallenave J-M. Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des 2003, 9:25-38.
14. Roth M. Pathogenesis of COPD. Part III. Inflammation in COPD. Int J Tuberc Lung Dis 2008, 12:375-380.
15. Riley D.A., Allin E.F. The effect of inactivity, programmed stimulation, and denervation on the histochemistry of skeletal muscle fiber types. Exp Neurol 1973, 40:391-413.
16. Larsen A.I., Lindal S., Aukrust P., Toft I., Aarsland T., Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol 2002, 83:25-32.
17. Eid A.A., Ionescu A.A., Nixon L.S., et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Crit Care Med 2001, 164:1414-1418.
18. van Helvoort H.A.C., Heijdra Y.F., de Boer R.C.C., Swinkelms A., Thijs H.M.H., Dekhuijjsen R. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 2008, 131:439-445.
19. Vogiatzis I., Stratakos G., Simoes D.C.M., et al. Effects of rehabilitative exercise on peripheral muscle TNFa, IL-6, IGF-I and MyoD expression of patients with COPD. Thorax 2007, 62:950-956.
20. Ding Y.-Z., Fu S., Szamarin D., Bromberg J. Interleukin-10 2003, Elsevier, New York.
21. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol (London) 2004, 515:287-291.
22. Smith D.A., Irving S.D., Sheldon J., Cole D., Kaski J.C. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001, 104:756-761.
23. Long P., Gassner R., Argarwal S. Tumor necrosis factor a-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitro. Arthritis Rheum 2001, 44:2311-2319.
24. Malm C. Exercise induces muscle damage and inflammation-fact or fiction?. Acta Physiol Scand 2001, 171:233-239.
25. Starkweather A.R. The effects of exercise on perceived stress and IL-6 levels among older adults. Biol Res Nurs 2007, 8:186-194.
26. Winkelman C., Higgins P.A., Chen Y.-J.K., Levin A. Cytokines in chronically critically ill patients after activity and rest. Biol Res Nurs 2007, 8:261-271.
27. Reid M.B., Li Y-P. Tumor necrosis factor-a and muscle wasting: a cellular perspective. Respir Res 2001, 2:269-272.
28. Seifert C., Dempfle A., Plagens A., et al. TNF-alpha, TNF-beta, IL-6 and IL-10 promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005, 65:93-100.
29. Gallagher O.M., Lowe G., Fitzgerald T., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003, 58:154-156.
30. Opal S.M., Huber C.E. The role of interleukin-10 in critical illness. Curr Opin Infect Dis 2000, 13:221-226.
31. Ford E.S. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology 2002, 13:561-568.
32. Kelley G.A., Kelley K.S. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 2006, 55:1500-1507.
33. Pedersen B.K., Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sport 2006, 16:3-63.
34. Plaisance E.P., Grandjean P.W. Physical activity and high-sensitivity C-reactive protein. Sports Med 2006, 35:443-458.
35. Fischer C.P., Bernsten A., Perstrup L.B., Eskildsen P., Pedersen B.K. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sport 2007, 17:580-587.
36. Green G.B., Harris I.S., Lin G.A., Moylan K.C. The Washington manual 2004, Lippincott Williams & Wilkins, St. Louis.
37. Rhodes S.G., Graham S.P. Is " timing" important for cytokine polarization?. Trends Immunol 2002, 23:246-249.
38. Pedersen B.K. Exercise and cytokines. Immunol Cell Biol 2000, 78:532-535.
39. Knaus W., Wagner D., Draper E., et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
40. Knebel A.R., Shekelton M.E., Burns S., Clochesy J.M., Goodnough S.K., Ingersoll G.L. Weaning from mechanical ventilatory support: refinement of a model. Am J Crit Care 1998, 7:149-152.
41. Hall C., Body L. Therapeutic exercise: moving toward function 1999, Lippincott, Philadelphia.
42. Lane L., Winslow E., Wood R.J., Dixon J. Dangling practices of 51 nurses: a pilot project. Am J Crit Care 1991, 6:177-182.
43. Tyron W. Activity measurement in psychology and medicine 1991, Plenum Press, New York.
44. Bauldoff G.S., Ryan-Wegner N.A., Diaz P.T. Wrist actigraphy validation of exercise movement in COPD. Wet J Nurs Res 2007, 29:789-802.
45. Winkelman C., Higgins P.A., Chen Y-J.K. Measuring activity in the chronically critically ill. Dimens Crit Care Nurs 2005, 24:281-290.
46. Grap M.J., Borchers C.T., Munro C.L., Elswick R.K., Sessler C.N. Actigraphy in the critically ill: correlations with activity, agitation, and sedation. Am J Crit Care 2005, 14:52-63.
47. Vogiatzis I., Stratakos G., Simoes D.C.M., et al. Effects of rehabilitative exercise on peripheral muscle TNFa, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 2007, 62:950-956.
48. Koechlin C., Couillard A., Cristol J.P., et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?. Eur Respir J 2004, 23:538-544.
49. Ionescu A.A., Micklebourough T.D., Lindley M.R., et al. Enhanced cytokine response to exercise in COPD. European Respiratory Society Annual Congress held in Munich 2006, 758. Nonin Medical, Inc, Lausanne, Switzerland.
50. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180.
51. Nevzorova A., Barkhatova A., Dochetkova A. Content of IL-6, IL-10 and TNFa in blood of COPD patients depending on body mass. European Respiratory Society Annual Congress held in Munich 2006, 761. Nonin Medical, Inc, Lausanne, Switzerland.
52. Petersen A.M.W., Penkova M., Iverson M., et al. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung 2007, 185:161-171.
53. Rabinovich R.A., Figueras M., Ardite E., et al. Increased tumor-necrosis factor-a plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 2003, 21:789-794.
54. Lacasse Y., Martin S., Lasserson T.J., Goldstein R.S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eur Medicophys 2007, 43:475-485.
55. Dolansky M.A., Moore S.M. Older adults' early disability following a cardiac event. West J Nurs Res 2008, 30:163-180.
56. Hill A.T., Bayley D., Stockley T.A. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999, 160:893-898.
57. Barnett M. Using a model in the assessment and management of COPD. J Community Nurs 2007, 21:8-10. 4,6.
58. Gross N.J. Outcome measures for COPD treatments: a critical evaluation. COPD 2004, 1:41-57.